Blood-brain barrier
More than 100 years ago it was discovered that if blue dye was injected into the bloodstream of an animal, that tissues of the whole body except the brain and spinal cord would turn blue. To explain this, scientists thought that a "Blood-Brain-Barrier" (BBB) which prevents materials from the blood from entering the brain existed. The BBB is semi-permeable; that is, it allows some materials to cross, but prevents others from crossing. In most parts of the body, the smallest blood vessels, called capillaries, are lined with endothelial cells. Endothelial tissue has small spaces between each individual cell so substances can move readily between the inside and the outside of the vessel. However, in the brain, the endothelial cells fit tightly together and substances cannot pass out of the bloodstream.
- Neuromyelitis Optica
- Cell based therapies
- Immunomodulation
- Brain-immune loop conjunction
- Ion channel disorder
- Disease confined to Blood Brain Barrier
- Vascular Neurology
Related Conference of Blood-brain barrier
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Chicago USA
2nd International Conference on Brain disorder and therapeutics
October 27- October 29 2016
Dubai UAE
2nd International Conference on Neurological Disorder and Stroke
April 28- April 30 2016
Manchester UK
2nd International Conference on Parasitology
August 01- August 03 2016
Melbourne Australia
Global Neuroscience conference
November 7- November 9 2016
London UK
5th Neurology Congress
March 14- March 16 2016
London UK
5th Alzheimer s disease and Dementia Conference
September 29-October 1 2016
Chicago USA
2nd Brain Disorders Conference
October 27- October 29 2016
Dubai UAE
2nd Neurological Disorders and Stroke Conference
April 28- April 30 2016
Valencia Spain
4th Vascular Dementia Conference
June 30-July 2 2016
Valencia Spain
4th International Conference on Vascular Dementia
June 30- July 2 2016
London NH
Barriers of the CNS Gordon Research Conference
June 17- June 22 2012
Stevenson WA
Blood Brain Barrier BBB Meeting
March 3- March 5 2016
Boston MA
Blood Brain Barrier congress
June 10-June 11 2015
Berlin Germany
2nd International Conference on Innate Immunity
July 21- July 22 2016
Rome Italy
International Conference on Hepatitis Vaccines
June 16- June 18 2016
Barcelona
BioMed Conference Blood Brain Barrier
2 Nov - 4 Nov 2015
Ottawa canada
Canadian society of allergy and clinical immunology annual meeting 2015
October 21 - october 24 2015
Sevilla Spain
Spanish society of allergy and clinical immunology 31st annual congress 2015
October 22 - October 24 2015
budapest hungery
2nd international primary immunodeficiencies congress 2015
November 5 - november 6 2015
San antonio united states
American college of allergy asthma and immunology annual meeting 2015
November 5 - november 9 2015
Lorne Australia
14th Transplantation science symposium 2015
November 11 - November 13 2015
Sapporo japan
Japanese society for immunology 44th annual meeting 2015
November 18 - November 20 2015
Canberra Australia
Australian society for immunology 45th annual meeting 2015
November 29 - December 3 2015
bleak Turkey
Turkish national allergy and clinical immunology association 22nd annual meeting 2015
November 29 - December 2 2015
Wien Austria
Austrian society of allergology and immunology annual symposium 2015
December 11 - December 12 2015
San diego ca united states
8th I mmunotherapeutics Immunomonitoring conference 2016
January 25 - January 26 2016
Banff alberta canada
keystone symposia cell biology and immunology of persistent infection 2016
January 31 - february 4 2016
Blood-brain barrier Conference Speakers
Recommended Sessions
- Antibody-mediated disorders
- Applied Neurobiology
- Autoimmune neuropathies
- Blood-brain barrier
- Brain-Computer Interface
- Clinical Neuroimmunology
- Fundamental immunology
- Neuro-immune interaction
- Neurodegenerative diseases
- Neuroimmunological infectious diseases
- Neuroimmunology
- Neuroinflammation
- Neurology
- Neuropharmacology
- Neurovirology
- Psychoneuroimmunology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance - Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Autoimmune & Inflammatory Disorders - Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Cancer Immunology & Tumor Microenvironment - Immunology 2026 (France)
- Cellular Signaling & Cell Fate Determination - Immunology 2026 (France)
- Clinical and Translational Immunology - Immunology 2026 (France)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunogenetics & Epigenetic Regulation - Immunology 2026 (France)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism - Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Immunotherapy & Immune Modulation - Immunology 2026 (France)
- Infectious Diseases - Antibiotics 2026 (UK)
- Infectious Diseases & Host–Pathogen Interactions - Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate and Adaptive Immune Mechanisms - Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Innovations in Cell Biology & Imaging Technologies - Immunology 2026 (France)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular & Cellular Immunology - Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Neuroimmunology & Brain–Immune Interactions - Immunology 2026 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Stem Cells & Regenerative Immunology - Immunology 2026 (France)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Vaccines & Vaccine Technology - Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)